Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.36 |
| ▸ | DPP4 | P27487 | 3/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13562722 | 0.91 | DPP4 (0.41) | DPP4PDK2 | |
| SCHEMBL13562714 | 0.84 | DPP4 (0.41) | DPP4PDK2 | |
| SCHEMBL19498028 | 0.82 | HDAC1 (0.32) | — | |
| SCHEMBL17624276 | 0.82 | HDAC9 (0.38) | HDAC9DPP4 | |
| SCHEMBL19498034 | 0.79 | — | — | |
| SCHEMBL13562717 | 0.78 | MEN1 (0.33) | — | |
| SCHEMBL19504437 | 0.76 | HDAC1 (0.38) | — | |
| SCHEMBL13562716 | 0.75 | DPP4 (0.39) | DPP4 | |
| SCHEMBL16152039 | 0.74 | DPP4 (0.43) | HDAC9DPP4 | |
| SCHEMBL18034942 | 0.74 | HDAC9 (0.40) | HDAC9DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170305922-A1 | CARM1 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305922-A1 | CARM1 INHIBITORS AND USES THEREOF | CARM1, ADRM1, PRMT1 | HDAC9 179/4885DPP4 4608/4885PDK2 3166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.